AEterna Zentaris Inc (consolidare)
Pagina dedicata companiei AEterna Zentaris Inc (consolidare) listata cu simbolul US.AEZSc
Descriere companie[edit | ]
Aeterna Zentaris Inc. (https://www.zentaris.com/) is a specialty biopharmaceutical company. The Company is focused on developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products focused on areas of significant unmet medical need. Its business is to finalize the development, manufacturing, registration and commercialization of Macrilen (macimorelin). Macrilen (macimorelin) is an orally available peptidomimetic ghrelin receptor agonist that stimulates the secretion of growth hormone by binding to the ghrelin receptor (GHSR-1a) and that has potential uses in both endocrinology and oncology indications. Macimorelin is the oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is leveraging the clinical and compelling safety profile of macimorelin in developing diagnosis of childhood-onset growth hormone deficiency (CGHD) in collaboration with Novo Nordisk.
Grafic actiuni companie[edit | ]